Atlas Trials

Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma

Clinical trial NCT05044676 · TERMINATED

Trial details

NCT number
NCT05044676
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
TERMINATED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2023-09-08
Primary completion
2025-09-22
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.